Arzneimittelforschung 2010; 60(6): 315-319
DOI: 10.1055/s-0031-1296293
Vasodilators
Editio Cantor Verlag Aulendorf (Germany)

Lipopolysaccharide-induced impairment of nitric oxide-mediated vasorelaxation and protective effects of nitric oxide synthesis inhibitors in isolated rat mesenteric arteries

Tomohiro Miike
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan
,
Mamoru Kanda
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan
,
Kazuyoshi Kunishiro
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan
,
Hiroaki Shirahase
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Kyoto, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
02 December 2011 (online)

Abstract

Isolated rat mesenteric arteries were in-cubated with lipopolysaccharide (LPS) for 6 h and then mounted in an organ bath to investigate their responses to various relaxants. Exposure to LPS moderately reduced acetylcholine (ACh)-induced endothelium-dependent relaxation (EDR),and markedly reduced sodium nitroprusside (SNP)-induced endothelium-independent relaxation (EIR). It did not affect ACh-induced EDR under treatment with a nitric oxide synthase (NOS) inhibitor,which is mediated by an endothelium-derived hyperpolarizing factor (EDHF),and forskolin-induced EIR. N-(3-(Amino-methyl)benzyl)acetamidine (1400 W), an inducible nitric oxide synthase (iNOS) inhibitor, actinomycin D, an RNA polymer-ase inhibitor, cycloheximide, a protein synthesis inhibitor, and dexamethazone reduced the nitric oxide (NO) production and reversed the reduced ACh-induced EDR and SNP-induced EIR. In LPS-treated mesenteric artery, L-arginine-induced relaxation was not affected by removal of endothelium, indicating muscular inducible nitric oxide synthase (iNOS) induction. Pre-exposure to SNP (NO donor) also moderately reduced ACh-induced EDR and markedly reduced SNP-induced EIR with little effect on ACh-induced EDHF-mediated EDR. In conclusion, in vitro exposure to LPS desensitized vascular smooth muscle cells to endogenous and exogenous NO by overproduction of muscular iNOS-derived NO, and an iNOS inhibitor and iNOS induction inhibitors prevented the LPS-induced desensitization.

 
  • References

  • 1 O’Brien Jr. JM, Ali NA, Aberegg SK, Abraham E. Sepsis. Am J Med. 2007; 120 (12) 1012-22
  • 2 Parratt JR. Nitric oxide in sepsis and endotoxemia. J Antimicrob Chemother. 1998; 41 (Suppl) 31-9
  • 3 Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology. 1993; 187 (3–5) 403-16
  • 4 Baker CH, Sutton ET. Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am J Physiol. 1993; 264 (4 Pt 2) H1118-23
  • 5 Fatehi-Hassanabad Z, Parratt JR, Furman BL. Endotoxininduced inhibition of mesenteric vasodilator responses to acetylcholine, bradykinin, and post-occlusion hyperemia in anesthetized rats. Shock. 1996; 6 (5) 371-6
  • 6 Mead PS, Guo JP, Lefer AM, Pierce S, Palladino M. Protective effects of a monoclonal antibody against lipid A in endotoxic shock. Methods Find Exp Clin Pharmacol. 1994; 16 (6) 405-12
  • 7 Piepot HA, Boer C, Groeneveld AB, vanLambalgen AA, Sipkema P. Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int. 2000; 57 (6) 2502-10
  • 8 Piepot HA, Groeneveld AB, vanLambalgen AA, Sipkema P. Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res. 2003; 110 (2) 413-8
  • 9 Boer C, Groeneveld AB, Scheffer GJ, deLange JJ, Westerhof N, Sipkema P. Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed rat pulmonary arteries. J Surg Res. 2005; 127 (2) 197-202
  • 10 Mitsumizo S, Nakashima M, Hamada T, Totoki T. NOS II inhibition restores attenuation of endothelium-dependent hyperpolarization in rat mesenteric artery exposed to lipo-polysaccharide. J Cardiovasc Pharmacol. 2004; 43 (4) 589-94
  • 11 Babu BR, Griffith OW. Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol. 1998; 2 (4) 491-500
  • 12 Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ et al 1400 W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997; 272 (8) 4959-63
  • 13 Oplinger JA, Garvey EP, Furfine ES, Shearer BG, Collins JL inventors; Wellcome Foundation Ltd., assignee. Acetami-dine derivatives and their use as inhibitors for the nitric oxide synthase. World patent WO9619440 1996 June 27
  • 14 Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol. 1997; 121 (7) 1383-91
  • 15 Shirahase H, Kanda M, Nakamura S, Tarumi T, Uehara Y, Ichikawa A. Inhibitory effects of PGD2, PGJ2 and 15-deoxy-D12,14-PGJ2 on iNOS induction in rat mesenteric artery. Life Sci. 2000; 66 (22) 2173-82
  • 16 Sayed N, Baskaran P, Ma X, vandenAkker F, Beuve A. De-sensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA. 2007; 104 (30) 12312-7
  • 17 Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J. 2003; Apr 17 (6) 773-5